ClinicalTrials.gg
RecruitingNCT065226073D_MoPalUpdated Sep 3, 2025

3D Analysis of Palatal Morphology of Growing Patients Treated With Rapid Palatal Expander.

An observational study in Cross-bite and Malocclusion in Children, sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Recruiting at 1 site in Italy. Open to participants aged 7 Years to 15 Years. Per ClinicalTrials.gov, last updated 2025-09-03.

Sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Observational

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Jul 2024; still recruiting 2 years 3 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
36
Ages
7 Years to 15 Years
Sex
All
01

Study summary

The aim of the present study is to assess the changes of palatal morphology among growing patients with different vertical facial growth patterns treated with rapid palatal expander.

Thirty-six patients referred to "Policlinico Agostino Gemelli" university hospital will be selected. The eligible criteria are posterior cross-bite, mixed dentition, skeletal Class I relationship and prepubertal stage of cervical vertebral maturation. The patients will be split into three groups according to facial divergency (hyper-, hypo-, normodivergent subjects). For each subject, digital dental casts will be recorded before and after treatment using an intraoral scanner. To evaluate two-dimensional maxillary arch changes, linear measurements will be done. To study comprehensively the palatal shape, a set of 240 landmark and semi-landmarks will be digitized on the palatal vault. Then, Geometric Morphometric Analysis (GMA) will be performed to compare morphological variations of the palate among different vertical facial growth pattern groups.

02

Conditions studied

  • Cross-bite
  • Malocclusion in Children

Browse trials for

03

In context

Malocclusion

323 studies on the registry are indexed under Malocclusion; 85 are open to participants now.

This study's planned enrollment of 36 is below the median of 63 across 74 observational studies indexed under Malocclusion.

Browse Malocclusion studies →

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS is the lead sponsor of 952 studies on the registry; 541 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Skeletal class 1 growing patients affected by cross-bite, coming to UOC Dental Clinic, Fondazione Policlinico Agostino Gemelli IRCCS will be enrolled for this study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Caucasian origin;
  • Mixed dentition stage;
  • Angle class I or straight step or mesial step molar relationship in primary dentition;
  • Skeletal class I (ANB angle between 0° and 5°);
  • Vertical dimension evaluated on lateral cephalograms: SN\^GoGn>37°: hyperdivergent, SN\^GoGn\<27°: hypodivergent, 27°\<SN\^GoGn>37°: normodivergent;
  • Cervical vertebral stage 1 or 2 (CVS methods 1-2);
  • Posterior cross-bite including deciduous or permanent teeth;
  • Presence of good quality pre-treatment records (history, intraoral and extraoral photographs, oral scan, panoramic radiographs, and lateral cephalometric radiographs with reference ruler);
  • Oral scan and photographs available for each subject 6 months after the beginning of the therapy;
  • Signing the form.

Exclusion criteria

Exclusion Criteria:

  • Previous orthodontic treatment;
  • Tooth agenesis or supernumerary teeth;
  • Craniofacial abnormalities;
  • Tooth impaction in the maxilla;
  • Torus palatinus;
  • History of dental trauma (avulsion and alveolar/jaw fracture);
  • Refusal to sign consent form.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
36 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Interventions

  • Devicerapid palatal expander

    Clinical evaluation of the patients who will be treated with rapid palatal expander for about 6 month.

06

What researchers measure

Primary outcomes

  1. Morphological changes of the palate

    The principal aim of this study is to analyze the morphological changes of the palate in growing subjects with posterior cross-bite after rapid palatal expander therapy. The intraoral scans of the maxillary arch will be recorded at T0 (before treatment) and T1 (after treatment). To study comprehensively the palatal shape, 3D Geometric Morphometric Method will be applied. Pre- and post-treatment intraoral scans will be digitized using Stratovan Checkpoint Software, placing 240 landmarks. The landmark configurations will be superimposed with Procrustes Superimposition.

    Time frame: 6 months

Secondary outcomes

  1. Geometric Morphometric Analysis of palatal vault among patients with different facial type

    The secondary aim of the present study is to compare three-dimensionally maxillary morphological changes after rapid palatal expander therapy among growing subjects with different facial type (hyperdivergent, hypodivergent, normal), using Geometric Morphometric Method. The facial type of each subject will be evaluated on lateral cephalograms, in particular focusing on the vertical skeletal pattern angle.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • UOC Clinica Odontoiatrica, Fondazione Poli..
    Roma, 00168, Italy
    Recruiting
    • Massimo Cordaro · Contact
    • Angelica Guastamacchia · Contact
    • Massimo Cordaro · Principal investigator
    • Patrizia Gallenzi · Sub investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Jul 2026, 24 months after the start.

Of 32 observational studies under Malocclusion, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 46. This study's planned 24 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
May 9, 2024
First posted
Jul 26, 2024
StartActual
Jul 17, 2024
Primary completionEst.
Jul 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Sep 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06522607
Responsible party
Sponsor
First posted
Jul 26, 2024
Start date
Jul 17, 2024
Primary completion
Jul 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 3, 2025

Study contacts

Massimo Cordaro
Contact
massimo.cordaro@policlinicogemelli.it
+393356309535
Angelica Guastamacchia
Contact
angelica.guastamacchia01@icatt.it
+393495015135
Massimo Cordaro
principal investigator · Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion